Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

A historic victory will lower drug costs for Pennsylvania’s seniors

Por: PennLive Opinion September 25, 2022

thumbnail

By Bill Johnston-WalshHere in Pennsylvania and across the country, millions of seniors will get relief from a new law that will help reduce out-of-control drug prices. For the first time in decades, Big Pharma’s relentless grip on their wallets, medicine cabinets and peace of mind will begin to pry loose.After years of calling on Congress to make prescription drugs more affordable, we won the fight for Medicare to negotiate lower drug prices... + full article



Similar News

ALS drug wins FDA approval despite questionable data

ABC News USA Health September 30, 2022

thumbnailWASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | ABC News


ALS drug wins FDA approval despite questionable data

ABC News USA Health September 30, 2022

thumbnailWASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | WPLG Local 10


ALS drug wins FDA approval despite questionable data

PennLive USA Nation September 30, 2022

thumbnailWASHINGTON — A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | ABC News


FDA approves controversial new drug designed to slow the progression of ALS

CNBC USA Health September 29, 2022

thumbnailThe Food and Drug Administration on Thursday approved a controversial new drug designed to slow the progress of Lou Gehrig's disease, a victory for patients and advocates despite limited evidence that the drug is effective.The drug, from the Massachusetts-based , joins... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | ABC News


Medicare premiums will drop next year. Here's how much you'll save.

CBS News USA Politics September 28, 2022

thumbnailAmerica's seniors are getting some good news about their health care expenses for 2023, with Medicare announcing that premiums for its Part B plan will drop next year by about 3%.The drop in pricing for Medicare's Part B plan, which covers routine doctor visits and... + más

Millions of Americans will save on Medicare fees next year | The Boston Globe

Millions of Americans will save on Medicare fees next year | ABC News


Fed Chair Powell warned of 'pain' to come. Seniors on fixed incomes are already feeling it

CNN USA Business September 27, 2022

thumbnailCNN  —  America’s seniors are facing a lot of hard choices. After the combination of climbing prices on everything from food to gas to utilities and ever-higher borrowing costs is making the finances of Americans on fixed incomes increasingly precarious. “Overall, they... + más

Fed Governors Shed No New Light On 4.6% Peak Funds Rate | Forbes

High inflation in sight, Fed to signal more rate hikes ahead | ABC News


Medicare Advantage plans will be more costly in 2022

Orlando Sentinel USA Health September 24, 2022

thumbnailIf ever there was a year to scrutinize your Medicare Advantage Plan choices, this is it. Costs in most plans are rising, but seniors will need to look carefully to figure out how and where they will be charged more. A drop in the average premium for Medicare Advantage plans can... + más

Medicare premiums will drop next year. Here's how much you'll save. | CBS News

Medicare Advantage 2021 enrollment deadlines | Orlando Sentinel



About iurex | Privacy Policy | Disclaimer |